[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346320-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346320-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","perceived-financial-toxicity-after-active-treatment-and-its-association-with-clinical-outcomes-among-breast-cancer-survivors-a-prospective-cohort-study","Perceived financial toxicity after active treatment and its association with clinical outcomes among breast cancer survivors: A prospective cohort study","","Perceived financial toxicity (FT) is an increasing concern for cancer survivors, yet its link to long-term oncologic results after completion of active treatment remains limited. A prospective cohort study followed 4163 breast cancer survivors from South Korea; participants were within 18 months of diagnosis, had finished surgery and adjuvant therapy, and had no recurrence at enrollment. FT was measured with the COST questionnaire, and associations were tested with Cox models for recurrence-free survival, mortality, and quality-of-life domains.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/perceived-financial-toxicity-after-active-treatment-and-its-association-with-clinical-outcomes-among-breast-cancer-survivors-a-prospective-cohort-study/346320/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/perceived-financial-toxicity-after-active-treatment-and-its-association-with-clinical-outcomes-among-breast-cancer-survivors-a-prospective-cohort-study/346320.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",17,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was perceived financial toxicity (FT) measured in the study?","Question",{"text":63,"@type":64},"FT was assessed using the Comprehensive Score for Financial Toxicity (COST) questionnaire, with FT defined as a COST score \u003C 26.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What study outcomes were used to evaluate clinical impact?",{"text":68,"@type":64},"The primary outcome was recurrence-free survival, and secondary outcomes included all-cause mortality and quality-of-life domains.",{"name":70,"@type":61,"acceptedAnswer":71},"What association did FT show with long-term outcomes after active treatment?",{"text":72,"@type":64},"FT was independently associated with increased risk of recurrence or death and with higher all-cause mortality, along with worse emotional, social, and future outlook functioning.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346320,1790114032,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":102,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":22,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","The Breast 85 (2026) 104697  \nContents lists available at ScienceDirect  \nThe Breast  \njournal [homepage:](homepage: www.journals.elsevier.com/the-breast)[ www.journals.elsevier.com/the-breast](homepage: www.journals.elsevier.com/the-breast)  \n| Perceived financial toxicity after active treatment and its association with   clinical outcomes among breast cancer survivors: A prospective\u003Cbr>cohort study\u003Cbr>Doyoun Woena,1, Danbee Kang b,c,d,1, Juwon Park d, Hyunsoo Kim b,d, Su Min Leea, Seok Jin Nama, Seok Won Kim a, Jeong Eon Lee a, Jong Han Yu a, Byung Joo Chaea, Jai Min Ryu a, Woong Ki Parka, Juhee Cho b,c,d, Se Kyung Lee a,* \u003Cbr>a Department of Surgery, Division of Breast Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea b Center for Clinical Epidemiology, Samsung Medical Center, Seoul, Republic of Korea\u003Cbr>c Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea\u003Cbr>d Trend Sensing and Risk Modeling Center, Institution of Quality of Life in Cancer, Samsung Medical Center, Seoul, Republic of Korea |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R C T |\n| Keywords:\u003Cbr>Breast cancer Financial toxicity Survivorship Recurrence Mortality Prospective study |  | Background: Perceived financial toxicity (FT) is an increasingly recognized concern among cancer survivors. However, its association with long-term oncologic outcomes, particularly after completion of active treatment, remains underexplored.\u003Cbr>Methods: We conducted a prospective cohort study of 4163 breast cancer survivors from a tertiary cancer center in South Korea. Eligible participants were within 18 months of diagnosis, had completed surgery and any adjuvant chemotherapy or radiotherapy, and had no evidence of recurrence at enrollment. Perceived FT was assessed using the Comprehensive Score for Financial Toxicity (COST) questionnaire. FT was defined by a COST score \u003C26. Primary outcome was recurrence-free survival (RFS), and secondary outcomes included all-cause mortality and quality-of-life (QoL) domains. Multivariable Cox proportional hazard models adjusted for age, stage, treatment, and socioeconomic factors.\u003Cbr>Results: Among the cohort, 2109 (50.7 %) patients reported perceived FT after active treatment. FT was independently associated with increased risk of recurrence or death (HR 1.42, 95 % CI 1.08–1.87), and higher allcause mortality (HR 1.74, 95 % CI 1.02–2.97). FT was also associated with significantly worse emotional functioning, social functioning, and future outlook.\u003Cbr>Conclusions: Perceived financial toxicity following active breast cancer treatment was associated with worse oncologic and quality-of-life outcomes, regardless of objective socioeconomic status. These findings underscore the need for routine assessment of perceived financial burden during survivorship care and targeted financial interventions, even in patients without traditionally defined financial vulnerability. |\n\n1. Introduction  \nCancer is an expensive and stressful disease [1,2]. As novel efficacious therapies are increasingly being used to treat cancer, the financial burden on patients is becoming bigger with relatively higher out-of-pocket (OOP) expenses for treatment [3,4]. Furthermore, cancer patients are forced to reduce work hours or stop working entirely due to  \ntheir diagnosis and treatment [5]. Thus, cancer patients faced increased concerns about affordability in terms of increasing financial toxicity (FT) [6,7]. A systematic review and meta-analysis found that 56.1 % of cancer patients experience catastrophic health expenditures as a consequence [8].  \nPrevious studies have reported that FT is associated with poor psychological health. Patients who had financial problems had a 2.56 times  \n* Corresponding author. Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine 81 Irwon-ro, Gangnam-gu,","cbCaiaNoHju8OLwj","https://ap.wps.com/l/cbCaiaNoHju8OLwj","pdf",790579,"English","# Introduction\n## Background: financial toxicity and survivorship challenges\n## Rationale: gap in longitudinal evidence after active treatment","[{\"question\":\"How was perceived financial toxicity (FT) measured in the study?\",\"answer\":\"FT was assessed using the Comprehensive Score for Financial Toxicity (COST) questionnaire, with FT defined as a COST score \\u003c 26.\"},{\"question\":\"What study outcomes were used to evaluate clinical impact?\",\"answer\":\"The primary outcome was recurrence-free survival, and secondary outcomes included all-cause mortality and quality-of-life domains.\"},{\"question\":\"What association did FT show with long-term outcomes after active treatment?\",\"answer\":\"FT was independently associated with increased risk of recurrence or death and with higher all-cause mortality, along with worse emotional, social, and future outlook functioning.\"}]","Perceived financial toxicity after active treatment and its association with clinical outcomes among breast cancer survivors: A prospective cohort study | PDF",1790060911,15,[147],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/af66be5f4534db72b86cedcf5508341a.webp",983,1310]